NEXTERONE (AMIODARONE HCI)
NEXTERONE (AMIODARONE HCI) is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including NEXTERONE (AMIODARONE HCI). Available dosage form: injection, solution.
Drug details
- Generic Name
- NEXTERONE (AMIODARONE HCI)
- Brand Names
- NEXTERONE (AMIODARONE HCI)
- Application Number
- NDA022325
- Sponsor
- HF Acquisition Co LLC, DBA HealthFirst
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- AMIODARONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS & USAGE NEXTERONE is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. NEXTERONE also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with NEXTERONE, patients may be transferred to oral amiodarone therapy [see Dosage and Administration ( 2 )]. Use NEXTERONE for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but NEXTERONE may be safely administered for longer periods if necessary.